Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Postmenopausal hormone replacement therapy and risk of cancer debated
July 28th, 2005
Link between postmenopausal hormone replacement therapy and risk of breast cancer remains debatable. "Observational studies provide evidence that breast cancer risk is increased with long-term oral use of postmenopausal estrogen replacement therapy (ET). Various large cohort studies have shown that the addition of a progestogen in combined hormone replacement therapy (EPT) increases this risk further," scientists writing in the journal Maturitas report. "Prospective, randomized controlled trials have confirmed this for the continuous combined regimen. So, why not tell our patients, 'Stop using ET and EPT, it is dangerous to your health' The...
Source: Women's Health Weekly (2005-07-28)
|
